Vitamin D deficiency is associated with an increased risk of subclinical atherosclerosis. To explore the potential link of the serum vitamin D level with carotid atherosclerosis, this meta-analysis assessed the correlation between vitamin D and carotid intima-media thickness as well as carotid atherosclerotic plaque. PubMed, Embase, Web of Science, and Cochrane Library databases were searched until the end of March 2017. Clinical studies investigating the relationship between vitamin D and carotid atherosclerosis were included. The outcome data were extracted according to the inclusion criteria and pooled for an effect estimate by a random-effects model. Of the 506 initially retrieved studies, 11 studies involving a total of 16,434 participants were included in the meta-analysis. Newcastle-Ottawa Quality Assessment Scale scores suggested that the included studies were of high quality. The pooled effects estimate showed that the serum vitamin D level was negatively associated with carotid atherosclerosis (odds ratio, 0.95; 95% confidence interval [CI], 0.93-0.96), with substantial heterogeneity among the individual studies (I 2 5 54%). Furthermore, a subgroup analysis suggested that hypovitaminosis D was associated with an 0.85-fold decrease in the odds of having a higher carotid intima-media thickness (95% CI, 0.76-0.96; P < .05; I 2 5 69%). Additionally, the pooled analysis also indicated that the serum vitamin D level was a protective factor against increased carotid plaque (odds ratio, 0.95; 95% CI, 0.93-0.97; P < .05; I 2 5 29%). Funnel plots and the Egger regression test showed the absence of a publication bias. In this metaanalysis, we comprehensively revealed a close link between vitamin D deficiency and carotid atherosclerosis. Patients with hypovitaminosis D might have extra requirements for preventive and therapeutic measures against early atherosclerosis, thus reducing the cardiovascular disease risk in the long term.
V itamin D is recognized as a crucial micronutrient for the metabolism of calcium and phosphorus, which are essential for muscle and osseous tissue. 1, 2 Additionally, increasing epidemiologic evidence indicates that vitamin D deficiency (defined as a serum 25-hydroxyvitamin D [25(OH)D] level < 75 nmol/L) is additionally linked to a series of diseases, including cardiovascular disease (CVD). [3] [4] [5] A low circulating 25(OH)D concentration is suggested as a cardiovascular risk factor, consistently associated with an increased risk of stroke, myocardial infarction, and cardiovascular mortality. 6 Furthermore, there is increasing interest in the relationship between vitamin D deficiency and the pathogenesis of atherosclerotic CVD, especially in the early stage. 7, 8 Vitamin D not only may influence the endothelial or smooth muscle vascular cell directly but also can be involved in immune or inflammatory modulation, thus contributing to an imbalance of vascular homeostasis, decreased arterial compliance, and development or progression of atherosclerosis. 9 Recently, a spectrum of studies reported that vitamin D is inversely associated with early atherosclerosis independent of various traditional risk factors. 10, 11 Conventionally, subclinical atherosclerosis is measured by an increased carotid intima-media thickness, defined as the distance between the intimal-luminal and medialadventitial interfaces of the artery wall, or the presence of carotid atherosclerotic plaque. 12 As accessible surrogate markers of atherosclerotic disease, these indicators can be effectively determined noninvasively by carotid ultrasonography. They not only facilitate an assessment of the impact of cardiovascular risk factors in the short term but also have predictive value for cardiovascular events in the general. Previous epidemiologic data have shown a significant association between hypovitaminosis D and carotid atherosclerosis after adjustments for conventional confounding factors. 13 However, current evidence evaluating the correlation of circulating vitamin D levels with carotid atherosclerosis is still limited, and it remains controversial, whereas negative findings have also been reported. Still, there is no convincing evidence from randomized trials supporting the idea that vitamin D supplements can ameliorate carotid atherosclerosis or reduce the CVD risk. In light of these premises, we aimed to perform a systematic review and meta-analysis to attain a comprehensive understanding on whether vitamin D deficiency is correlated with the carotid intima-media thickness and the presence of carotid plaque.
Methods

Search Strategy
Our analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Metaanalyses statement. 14 We performed a systematic literature search of PubMed, Embase, Web of Science, and Cochrane Library databases up to May 30, 2017 . A combined text and medical subject heading search strategy was used with the terms "hypovitaminosis D," "25-hydroxyvitamin D," "vitamin D," "25(OH)D," "intima-media thickness," "carotid intima-media thickness," "carotid plaque," "carotid atherosclerosis," "cardiovascular disease," "subclinical atherosclerosis," and "preclinical atherosclerosis." The search was restricted to studies in human beings without language restrictions. Reference lists in the identified articles were also searched manually for potentially relevant publications.
Inclusion Criteria
Criteria for inclusion of a trial in this systematic review were as follows: (1) prospective design, retrospective design, or cross-sectional design; (2) original studies designed to evaluate the association between the serum vitamin D level and carotid intima-media thickness and carotid plaque; (3) estimations of odds ratios (ORs) or hazard ratios with confidence intervals (CIs) or calculation with sufficient data; and (4) examination of carotid atherosclerosis based on ultrasonography. Duplicated reports, letters, case reports, reviews, and editorials were deleted, according the titles and abstracts. Furthermore, studies were also excluded if they failed to provide information to calculate the point estimate for the outcome of interest.
Study Selection and Data Extraction
Two investigators (T.L. and L.X.) independently reviewed the full text of the retrieved studies after the first screening of titles/abstracts according to the inclusion and exclusion criteria. Relevant characteristics of the included studies were extracted into an electronic database: (1) study, including first author, date of publication, location, and design; (2) participants, including number, age, and sex; (3) evaluation/indicator of carotid atherosclerosis; and (4) adjusted confounders. The most adjusted estimate was preferred when a study reported more than 1 risk estimate. Any disagreements regarding the extraction of data were resolved by an additional investigator (L.Z.).
Quality Assessment
The methodological quality of the included studies was assessed independently by 2 reviewers (T.L. and L.X.) using the Newcastle-Ottawa Quality Assessment Scale. The quality of each included study ranged from 1 to 9 stars and was based on 3 aspects: (1) selection of the participants; (2) comparability of groups; and (3) evaluation of the outcome/exposure. Any possible disagreements in the quality evaluation were subsequently addressed by a third reviewer.
Statistical Analyses
The results of the studies were pooled to make an overall estimate of the OR/hazard ratio with 95% CI based on the inverse variance method. Clinical heterogeneity was assessed by the v 2 test and quantified by the I 2 statistic, which if less than 25% was minimal, 25% to 49% was moderate, and greater than 50% was substantial. A random-effects model by the Der Simonian and Laird method was selected when taking into account significant heterogeneity among studies, contributing to a more conservative estimate compared to the fixedeffects model. As for the weight in the inverse-variance method with a random-effects model, it assumes 2 sources of variability in effects: 1 from sampling error and 1 from study level differences, which represent the variability across population effects. Additionally, a sensitivity analysis was conducted by eliminating each study at a time and determining its effect on the ultimate effect estimate. P of < .05 was considered statistically significant for all of the analyses. Funnel plots and the Egger regression test were performed to examine the presence of a publication bias. Statistical analyses were performed with Review Manager version 5.3 software (Nordic Cochrane Center, Cochrane Collaboration, Copenhagen, Denmark).
Results
Search Results
A Preferred Reporting Items for Systematic Reviews and Meta-analyses flowchart illustrating the literature search process is shown in Figure 1 . The electronic search retrieved a total of 506 potentially relevant publications, which after the initial screening resulted in removal of 396 articles according to titles and abstracts. By reviewing the full articles, 51 articles were further rejected for the following reasons: (1) data were unavailable to calculate the OR/hazard ratio (eg, quantitative variables); (2) no outcome data of interest were included; and (3) the study was a basic research/review article or not related. Finally, 11 studies were eligible for inclusion in our analysis. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Baseline Characteristics of the Studies Table 1 outlines the main characteristics of the studies included in the meta-analysis. Overall, our analysis included 11 observational studies enrolling a total of 16,434 participants. Among them, all of the studies were cross-sectional, with sample sizes varying from 40 to 3251 participants (either community based or hospital based). These studies were conducted in Asia (China and Korea), Europe (Spain, Italy, Finland, and United Kingdom), and North America (United States). Most of the studies adjusted confounding factors such as age, sex, smoking, hypertension, diabetes, dyslipidemia, and others. In terms of the quality assessment, the Newcastle-Ottawa Quality Assessment Scale scores suggested that the included studies were of high quality.
Association Between Serum Vitamin D Level and Carotid Atherosclerosis
The distribution of studies by estimates of the association between the serum vitamin D level and carotid atherosclerosis is plotted in Figure 2 . A total of 11 included studies with 15 comparisons provided data suitable for the pooled primary analysis. This analysis revealed that the serum vitamin D level was negatively associated with carotid atherosclerosis (OR, 0.95; 95% CI, 0.93-0.96). With respect to statistical heterogeneity, we found evidence of heterogeneity across the included studies (I 2 5 54%; P for heterogeneity < .05). There was no remarkable asymmetric appearance in the funnel plot, and the Egger regression test (P > .05) also showed the absence of a publication bias ( Figure 3) .
Next, a subgroup analysis was conducted for carotid intima-media thickness and plaque, respectively ( Figure  2 ). In the case of intima-media thickness, 4 studies with 3761 individuals were included. Pooled data suggested that hypovitaminosis D was associated with a 0.85-fold decrease in the odds of having a higher carotid intimamedia thickness (95% CI, 0.76-0.96; P < .05; I 2 5 69%). As for the presence of plaque, 8 observational studies with 12,744 individuals were involved. The pooled analysis showed that serum vitamin D was a protective factor against an increased risk of carotid plaque (OR, 0.95; 95% CI, 0.93-0.97; P < .05; I 2 5 29%). Finally, an exclusion sensitivity analysis had no effect on the overall estimate (data not shown).
Discussion
In this systematic review and meta-analysis, we revealed a close link between hypovitaminosis D and carotid atherosclerosis based on 11 observational studies involving a total of 16,434 participants. Interestingly, the subgroup analysis also yielded consistent results for carotid intimamedia thickness and plaque. Nevertheless, substantial heterogeneity was found across the included studies. The likelihood of a publication bias was small. To our knowledge, this work was the first meta-analysis that collectively assessed the correlation between vitamin D and carotid atherosclerosis. As mentioned above, emerging clinical and epidemiologic evidence supported an association between a low serum vitamin D level and an increased risk of carotid atherosclerosis, which was independent of conventional risk factors. However, several studies demonstrated no evidence of a relationship between vitamin D and carotid atherosclerosis after adjustment for potential confounders. [26] [27] [28] [29] Blondon et al 16 found no independent associations between 25(OH)D and carotid intima-media thickness at baseline (increment of 1.9 lm [95% CI, -5.1 to 8.9 lm] per 10 ng/mL lower 25(OH)D after adjustment for body mass index). Furthermore, clinical trials and a metaanalysis showed that vitamin D-raising interventions failed to show a significant reduction in cardiovascular risk even with an increase in the serum vitamin D level. 30, 31 Despite these controversial findings, our results are in line with most epidemiologic studies showing that vitamin D is inversely associated with increased carotid intima-media thickness and plaque.
Carotid atherosclerosis serves as a mirror of the generalized atherosclerotic burden and the progression of subclinical atherosclerosis, providing a prognostic value for future cardiovascular events. It is noteworthy that carotid intima-media thickness and plaque are proven to reflect different pathologic states of carotid atherosclerosis, although they are both recognized as conventional indicators of subclinical atherosclerosis.
12,32 Carotid intima-media thickness is subject to the influence of age and blood pressure, whereas carotid plaque is a distinct result of atherosclerotic intimal thickening. Thus, carotid plaque is recommended as a more valid predictor, with Data are presented as mean 6 SD where applicable. BP indicates blood pressure; BMI, body mass index; CIMT, carotid intima-medial thickness; CP, carotid plaque; GFR, glomerular filtration rate; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; LDL-C, low-density lipoprotein cholesterol; NA, not available; pSoBid, Psychological, Social and Biological Determinants of Ill Health; TG, triglyceride; and WC, waist circumference.
a The Newcastle-Ottawa Quality Assessment Scale was used for quality assessment, with scores of 1 to 3, 4 to 6, and 7 to 9 for low-, intermediate-, and high-quality studies, respectively.
higher diagnostic accuracy than carotid intima-media thickness in terms of predicting early atherosclerosis and further CVD events. 33 There are several potential pathophysiologic mechanisms through which a vitamin D deficiency might contribute to the pathogenesis of carotid atherosclerosis. 34 The pleiotropic effects of vitamin D are implicated in endothelial dysfunction, vascular proliferation and calcification, oxidative stress, inflammation, the renin angiotensin aldosterone system, and others. 35 First, vitamin D receptors are expressed in endothelial and vascular smooth muscle cells, whose activation shows potential benefits in both endothelial function and the vessel wall. 36, 37 Vitamin D can modulate the excessive oxidative-inflammatory response, balance between vasodilatation and vasoconstriction, arterial remodeling, angiogenesis, and thrombus formation. 38 Additionally, it protects the arterial wall via regulation of the expression/activity of local macrophages and T lymphocytes. 39 Second, vitamin D is able to improve defective insulin secretion and insulin resistance, which pave the way for the genesis and progression of atherosclerosis. 40 Specifically, vitamin D might activate its receptors in pancreatic islet b cells and balance the calcium homeostasis between intracellular and extracellular. 41 Third, vitamin D is known as an endocrine suppressor of the renin angiotensin aldosterone system and renin biosynthesis, subsequently reducing the risk of hypertension and atherosclerosis. 42 Finally, a vitamin D deficiency is associated with higher low-density lipoprotein cholesterol and lower high-density lipoprotein cholesterol levels and an increased parathyroid hormone level, which play an independent role in atherosclerosis development and adverse cardiovascular events. 43 Further studies are still warranted to elucidate the complex interaction between vitamin D and the process of atherosclerosis.
Still, our meta-analysis has to be interpreted in view of certain limitations as follows: First, all of the included studies were observational, which might affect the validity of the overall results. Owing to the cross-sectional design, interpretation of causality between serum 25(OH)D and the development of carotid atherosclerosis should be made cautiously. On the other hand, data from cross-sectional and cohort studies might convey different information when it comes to the assessment of atherosclerosis. The former was suggested as a single point on an atherosclerosis-versus-time curve, whereas the latter might correlate with the slope of that curve. 44 Thus, it is better to analyze cross-sectional data separately from progression data. Due to the limited number of cohort studies up to now, we did not include data on intima-media thickness progression in this work. Hopefully, we will investigate the association between vitamin D and intima-media thickness progression if more cohort studies are available in the future. Thus, longitudinal studies are further required to sort out the time Figure 2 . Effect estimate for the association between the serum vitamin D level and increased carotid artery intima-media thickness and carotid plaques using a random-effects model. sequence of events. Given the single-center nature of some included studies with relatively small sample sizes, they are also inevitably prone to a selection bias and might lead to an overestimate of the effect. Second, a 1-time 25(OH)D measurement may not reflect an individual's lifetime status, which might be substantially affected by the winter season, smoking, physical inactivity, and diet. Third, the diversity in study designs, ethnic differences, population characteristics, and the accuracy of ultrasonography in assessing carotid atherosclerosis leads to heterogeneity across studies, which may restrict the interpretation of the effect estimates and give misleading results. 45 Nevertheless, a subgroup analysis according to the study design or specific population was not possible in light of the limited number of related studies up to now. In this study, the heterogeneity was substantial (I 2 5 54%) and was partly addressed by the randomeffects model. Additionally, we cannot exclude potential selection and information biases as well as residual cofounders, including the socioeconomic status and lifestyle patterns such as food intake and functional activity, which may affect the vitamin D status. Thus, the findings provided by this meta-analysis should be interpreted with caution.
In conclusion, this study collectively demonstrates an independent correlation between hypovitaminosis D and carotid atherosclerosis. Especially, this relationship turns out to be more prominent in patients with existing carotid plaque than in those with merely increased carotid intima-media thickness. It is plausible to suppose that plaque might be a more useful marker for assessing the effects of vitamin D on atherosclerosis. From a clinical perspective, our results suggest that a low circulating vitamin D level should be recognized as a possible risk factor for atherosclerotic CVD. Given the high prevalence of CVD and higher mortality from cardiovascular causes, individuals with hypovitaminosis D might have extra requirements for preventive and therapeutic measures against early atherosclerosis. From a public health perspective, there is a realistic need for large-scale prospective studies to further verify such a relationship and elucidate the mechanisms that link 25(OH)D to carotid atherosclerosis. Further follow-up and interventional studies are also required to determine whether dietary or supplementary vitamin D might protect blood vessels and prevent the formation or acceleration of carotid atherosclerosis-related CVD events in healthy adults.
